<unk>  is an antiandrogen that is FDA approved for the treatment of Stage D2 metastatic carcinoma of the prostate in combination with a luteinizing hormone-releasing hormone (LHRH) analog.   Common adverse reactions include hot flashes, general pain, back pain, pelvic pain and abdominal pain, asthenia, constipation, infection, nausea, peripheral edema, dyspnea, diarrhea, hematuria, nocturia and anemia..
Bicalutamide
Apalutamide
Nilutamide
Flutamide
Carbutamide
Enzalutamide
Goserelin
Anastrozole